▶ 調査レポート

フルミオキサジンのグローバル市場インサイト・予測(~2028年)

• 英文タイトル:Global Flumioxazin Market Insights, Forecast to 2028

QYResearchが調査・発行した産業分析レポートです。フルミオキサジンのグローバル市場インサイト・予測(~2028年) / Global Flumioxazin Market Insights, Forecast to 2028 / QY2207C0009資料のイメージです。• レポートコード:QY2207C0009
• 出版社/出版日:QYResearch / 2022年7月15日
• レポート形態:英文、PDF、96ページ
• 納品方法:Eメール(納期:3日)
• 産業分類:農業
• 販売価格(消費税別)
  Single User¥725,200 (USD4,900)▷ お問い合わせ
  Multi User¥1,087,800 (USD7,350)▷ お問い合わせ
  Enterprise License¥1,450,400 (USD9,800)▷ お問い合わせ
• ご注文方法:お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法:銀行振込(納品後、ご請求書送付)
レポート概要
新型コロナウイルス感染症のパンデミックにより、世界のフルミオキサジンの市場規模は2022年にUS$xxxと推定され、調査期間中のCAGRはxxx%で、2028年までに再調整された規模はUS$xxxになると予測されています。この医療危機による経済変化を十分に考慮すると、2021年にフルミオキサジンの世界市場のxxx%を占める「工業材料」タイプは、2028年までにUS$xxxの規模になり、パンデミック後の修正xxx%CAGRで成長すると予測されています。一方、「大豆」セグメントは、この予測期間を通じてxxx%のCAGRに変更されます。
中国のフルミオキサジンの市場規模は2021年にUS$xxxと分析されており、米国とヨーロッパのフルミオキサジン市場規模はそれぞれUS$xxxとUS$xxxです。米国の割合は2021年にxxx%であり、中国とヨーロッパはそれぞれxxx%とxxx%です。中国の割合は2028年にxxx%に達し、対象期間を通じてxxx%のCAGRを記録すると予測されています。日本、韓国、東南アジアはアジアで注目市場であり、今後6年間のCAGRはそれぞれxxx%、xxx%、xxx%になる見通しです。ヨーロッパのフルミオキサジン市場については、ドイツは2028年までにUS$xxxに達すると予測されており、予測期間中のCAGRはxxx%になる見通しです。

フルミオキサジンのグローバル主要メーカーには、Sumitomo Chemical、Lier Chemical、Yifan Bio-tech Group、Shangyu Nutrichem、Rainbow Agro、Shandong Binnong Technology、ShanDong Cynda Chemical、Shandong Kesai Agrochem Holding、Maxunitechなどがあります。2021年、世界のトップ5プレイヤーは売上ベースで約xxx%の市場シェアを占めています。

フルミオキサジン市場は、種類と用途によって区分されます。世界のフルミオキサジン市場のプレーヤー、利害関係者、およびその他の参加者は、当レポートを有益なリソースとして使用することで優位に立つことができます。セグメント分析は、2017年~2028年期間のタイプ別および用途別の販売量、売上、予測に焦点を当てています。

【種類別セグメント】
工業材料、シングル製造、混合製造

【用途別セグメント】
大豆、サトウキビ、綿花、その他

【掲載地域】
北米:アメリカ、カナダ
ヨーロッパ:ドイツ、フランス、イギリス、イタリア、ロシア
アジア太平洋:日本、中国、韓国、インド、オーストラリア、台湾、インドネシア、タイ、マレーシア
中南米:メキシコ、ブラジル、アルゼンチン
中東・アフリカ:トルコ、サウジアラビア、UAE

【目次(一部)】

・調査の範囲
- フルミオキサジン製品概要
- 種類別市場(工業材料、シングル製造、混合製造)
- 用途別市場(大豆、サトウキビ、綿花、その他)
- 調査の目的
・エグゼクティブサマリー
- 世界のフルミオキサジン販売量予測2017-2028
- 世界のフルミオキサジン売上予測2017-2028
- フルミオキサジンの地域別販売量
- フルミオキサジンの地域別売上
- 北米市場
- ヨーロッパ市場
- アジア太平洋市場
- 中南米市場
- 中東・アフリカ市場
・メーカーの競争状況
- 主要メーカー別フルミオキサジン販売量
- 主要メーカー別フルミオキサジン売上
- 主要メーカー別フルミオキサジン価格
- 競争状況の分析
- 企業M&A動向
・種類別市場規模(工業材料、シングル製造、混合製造)
- フルミオキサジンの種類別販売量
- フルミオキサジンの種類別売上
- フルミオキサジンの種類別価格
・用途別市場規模(大豆、サトウキビ、綿花、その他)
- フルミオキサジンの用途別販売量
- フルミオキサジンの用途別売上
- フルミオキサジンの用途別価格
・北米市場
- 北米のフルミオキサジン市場規模(種類別、用途別)
- 主要国別のフルミオキサジン市場規模(アメリカ、カナダ)
・ヨーロッパ市場
- ヨーロッパのフルミオキサジン市場規模(種類別、用途別)
- 主要国別のフルミオキサジン市場規模(ドイツ、フランス、イギリス、イタリア、ロシア)
・アジア太平洋市場
- アジア太平洋のフルミオキサジン市場規模(種類別、用途別)
- 主要国別のフルミオキサジン市場規模(日本、中国、韓国、インド、オーストラリア、台湾、インドネシア、タイ、マレーシア)
・中南米市場
- 中南米のフルミオキサジン市場規模(種類別、用途別)
- 主要国別のフルミオキサジン市場規模(メキシコ、ブラジル、アルゼンチン)
・中東・アフリカ市場
- 中東・アフリカのフルミオキサジン市場規模(種類別、用途別)
- 主要国別のフルミオキサジン市場規模(トルコ、サウジアラビア)
・企業情報
Sumitomo Chemical、Lier Chemical、Yifan Bio-tech Group、Shangyu Nutrichem、Rainbow Agro、Shandong Binnong Technology、ShanDong Cynda Chemical、Shandong Kesai Agrochem Holding、Maxunitech
・産業チェーン及び販売チャネル分析
- フルミオキサジンの産業チェーン分析
- フルミオキサジンの原材料
- フルミオキサジンの生産プロセス
- フルミオキサジンの販売及びマーケティング
- フルミオキサジンの主要顧客
・マーケットドライバー、機会、課題、リスク要因分析
- フルミオキサジンの産業動向
- フルミオキサジンのマーケットドライバー
- フルミオキサジンの課題
- フルミオキサジンの阻害要因
・主な調査結果

Flumioxazin is a benzoxazinones-type herbicide used on soybeans, peanuts, orchard fruits and other crop. It is a diphenyl ether group G herbicide that functioning through inhibiting the protoorphyrinogen oxidase. As a light-dependent peroxidising herbicide (LDPH), it takes effect by blocking heme and chlorophyll biosynthesis resulting in the accumulation of phototoxic porphyrins, leading to the membrane damage and further killing the weeds.
Market Analysis and Insights: Global Flumioxazin Market
Due to the COVID-19 pandemic, the global Flumioxazin market size is estimated to be worth US$ million in 2022 and is forecast to a readjusted size of US$ million by 2028 with a CAGR of % during the forecast period 2022-2028. Fully considering the economic change by this health crisis, Technical Material accounting for % of the Flumioxazin global market in 2021, is projected to value US$ million by 2028, growing at a revised % CAGR from 2022 to 2028. While Soybean segment is altered to an % CAGR throughout this forecast period.
China Flumioxazin market size is valued at US$ million in 2021, while the US and Europe Flumioxazin are US$ million and US$ million, severally. The proportion of the US is % in 2021, while China and Europe are % and % respectively, and it is predicted that China proportion will reach % in 2028, trailing a CAGR of % through the analysis period 2022-2028. Japan, South Korea, and Southeast Asia are noteworthy markets in Asia, with CAGR %, %, and % respectively for the next 6-year period. As for the Europe Flumioxazin landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period 2022-2028.
The global key manufacturers of Flumioxazin include Sumitomo Chemical, Lier Chemical, Yifan Bio-tech Group, Shangyu Nutrichem, Rainbow Agro, Shandong Binnong Technology, ShanDong Cynda Chemical, Shandong Kesai Agrochem Holding and Maxunitech. etc. In 2021, the global top five players have a share approximately % in terms of revenue.
In terms of production side, this report researches the Flumioxazin capacity, production, growth rate, market share by manufacturers and by region (region level and country level), from 2017 to 2022, and forecast to 2028.
In terms of sales side, this report focuses on the sales of Flumioxazin by region (region level and country level), by company, by Type and by Application. from 2017 to 2022 and forecast to 2028.
Global Flumioxazin Scope and Segment
Flumioxazin market is segmented by Type and by Application. Players, stakeholders, and other participants in the global Flumioxazin market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on production capacity, revenue and forecast by Type and by Application for the period 2017-2028.
Segment by Type
Technical Material
Single Preparation
Compound Preparation
Segment by Application
Soybean
Sugar Cane
Cotton
Other
By Company
Sumitomo Chemical
Lier Chemical
Yifan Bio-tech Group
Shangyu Nutrichem
Rainbow Agro
Shandong Binnong Technology
ShanDong Cynda Chemical
Shandong Kesai Agrochem Holding
Maxunitech
Production by Region
North America
Europe
China
Japan
Consumption by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Colombia
Middle East & Africa
Turkey
Saudi Arabia
UAE

レポート目次

1 Study Coverage
1.1 Flumioxazin Product Introduction
1.2 Market by Type
1.2.1 Global Flumioxazin Market Size by Type, 2017 VS 2021 VS 2028
1.2.2 Technical Material
1.2.3 Single Preparation
1.2.4 Compound Preparation
1.3 Market by Application
1.3.1 Global Flumioxazin Market Size by Application, 2017 VS 2021 VS 2028
1.3.2 Soybean
1.3.3 Sugar Cane
1.3.4 Cotton
1.3.5 Other
1.4 Study Objectives
1.5 Years Considered
2 Global Flumioxazin Production
2.1 Global Flumioxazin Production Capacity (2017-2028)
2.2 Global Flumioxazin Production by Region: 2017 VS 2021 VS 2028
2.3 Global Flumioxazin Production by Region
2.3.1 Global Flumioxazin Historic Production by Region (2017-2022)
2.3.2 Global Flumioxazin Forecasted Production by Region (2023-2028)
2.4 North America
2.5 Europe
2.6 China
2.7 Japan
3 Global Flumioxazin Sales in Volume & Value Estimates and Forecasts
3.1 Global Flumioxazin Sales Estimates and Forecasts 2017-2028
3.2 Global Flumioxazin Revenue Estimates and Forecasts 2017-2028
3.3 Global Flumioxazin Revenue by Region: 2017 VS 2021 VS 2028
3.4 Global Flumioxazin Sales by Region
3.4.1 Global Flumioxazin Sales by Region (2017-2022)
3.4.2 Global Sales Flumioxazin by Region (2023-2028)
3.5 Global Flumioxazin Revenue by Region
3.5.1 Global Flumioxazin Revenue by Region (2017-2022)
3.5.2 Global Flumioxazin Revenue by Region (2023-2028)
3.6 North America
3.7 Europe
3.8 Asia-Pacific
3.9 Latin America
3.10 Middle East & Africa
4 Competition by Manufactures
4.1 Global Flumioxazin Production Capacity by Manufacturers
4.2 Global Flumioxazin Sales by Manufacturers
4.2.1 Global Flumioxazin Sales by Manufacturers (2017-2022)
4.2.2 Global Flumioxazin Sales Market Share by Manufacturers (2017-2022)
4.2.3 Global Top 10 and Top 5 Largest Manufacturers of Flumioxazin in 2021
4.3 Global Flumioxazin Revenue by Manufacturers
4.3.1 Global Flumioxazin Revenue by Manufacturers (2017-2022)
4.3.2 Global Flumioxazin Revenue Market Share by Manufacturers (2017-2022)
4.3.3 Global Top 10 and Top 5 Companies by Flumioxazin Revenue in 2021
4.4 Global Flumioxazin Sales Price by Manufacturers
4.5 Analysis of Competitive Landscape
4.5.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
4.5.2 Global Flumioxazin Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
4.5.3 Global Flumioxazin Manufacturers Geographical Distribution
4.6 Mergers & Acquisitions, Expansion Plans
5 Market Size by Type
5.1 Global Flumioxazin Sales by Type
5.1.1 Global Flumioxazin Historical Sales by Type (2017-2022)
5.1.2 Global Flumioxazin Forecasted Sales by Type (2023-2028)
5.1.3 Global Flumioxazin Sales Market Share by Type (2017-2028)
5.2 Global Flumioxazin Revenue by Type
5.2.1 Global Flumioxazin Historical Revenue by Type (2017-2022)
5.2.2 Global Flumioxazin Forecasted Revenue by Type (2023-2028)
5.2.3 Global Flumioxazin Revenue Market Share by Type (2017-2028)
5.3 Global Flumioxazin Price by Type
5.3.1 Global Flumioxazin Price by Type (2017-2022)
5.3.2 Global Flumioxazin Price Forecast by Type (2023-2028)
6 Market Size by Application
6.1 Global Flumioxazin Sales by Application
6.1.1 Global Flumioxazin Historical Sales by Application (2017-2022)
6.1.2 Global Flumioxazin Forecasted Sales by Application (2023-2028)
6.1.3 Global Flumioxazin Sales Market Share by Application (2017-2028)
6.2 Global Flumioxazin Revenue by Application
6.2.1 Global Flumioxazin Historical Revenue by Application (2017-2022)
6.2.2 Global Flumioxazin Forecasted Revenue by Application (2023-2028)
6.2.3 Global Flumioxazin Revenue Market Share by Application (2017-2028)
6.3 Global Flumioxazin Price by Application
6.3.1 Global Flumioxazin Price by Application (2017-2022)
6.3.2 Global Flumioxazin Price Forecast by Application (2023-2028)
7 North America
7.1 North America Flumioxazin Market Size by Type
7.1.1 North America Flumioxazin Sales by Type (2017-2028)
7.1.2 North America Flumioxazin Revenue by Type (2017-2028)
7.2 North America Flumioxazin Market Size by Application
7.2.1 North America Flumioxazin Sales by Application (2017-2028)
7.2.2 North America Flumioxazin Revenue by Application (2017-2028)
7.3 North America Flumioxazin Sales by Country
7.3.1 North America Flumioxazin Sales by Country (2017-2028)
7.3.2 North America Flumioxazin Revenue by Country (2017-2028)
7.3.3 United States
7.3.4 Canada
8 Europe
8.1 Europe Flumioxazin Market Size by Type
8.1.1 Europe Flumioxazin Sales by Type (2017-2028)
8.1.2 Europe Flumioxazin Revenue by Type (2017-2028)
8.2 Europe Flumioxazin Market Size by Application
8.2.1 Europe Flumioxazin Sales by Application (2017-2028)
8.2.2 Europe Flumioxazin Revenue by Application (2017-2028)
8.3 Europe Flumioxazin Sales by Country
8.3.1 Europe Flumioxazin Sales by Country (2017-2028)
8.3.2 Europe Flumioxazin Revenue by Country (2017-2028)
8.3.3 Germany
8.3.4 France
8.3.5 U.K.
8.3.6 Italy
8.3.7 Russia
9 Asia Pacific
9.1 Asia Pacific Flumioxazin Market Size by Type
9.1.1 Asia Pacific Flumioxazin Sales by Type (2017-2028)
9.1.2 Asia Pacific Flumioxazin Revenue by Type (2017-2028)
9.2 Asia Pacific Flumioxazin Market Size by Application
9.2.1 Asia Pacific Flumioxazin Sales by Application (2017-2028)
9.2.2 Asia Pacific Flumioxazin Revenue by Application (2017-2028)
9.3 Asia Pacific Flumioxazin Sales by Region
9.3.1 Asia Pacific Flumioxazin Sales by Region (2017-2028)
9.3.2 Asia Pacific Flumioxazin Revenue by Region (2017-2028)
9.3.3 China
9.3.4 Japan
9.3.5 South Korea
9.3.6 India
9.3.7 Australia
9.3.8 China Taiwan
9.3.9 Indonesia
9.3.10 Thailand
9.3.11 Malaysia
10 Latin America
10.1 Latin America Flumioxazin Market Size by Type
10.1.1 Latin America Flumioxazin Sales by Type (2017-2028)
10.1.2 Latin America Flumioxazin Revenue by Type (2017-2028)
10.2 Latin America Flumioxazin Market Size by Application
10.2.1 Latin America Flumioxazin Sales by Application (2017-2028)
10.2.2 Latin America Flumioxazin Revenue by Application (2017-2028)
10.3 Latin America Flumioxazin Sales by Country
10.3.1 Latin America Flumioxazin Sales by Country (2017-2028)
10.3.2 Latin America Flumioxazin Revenue by Country (2017-2028)
10.3.3 Mexico
10.3.4 Brazil
10.3.5 Argentina
10.3.6 Colombia
11 Middle East and Africa
11.1 Middle East and Africa Flumioxazin Market Size by Type
11.1.1 Middle East and Africa Flumioxazin Sales by Type (2017-2028)
11.1.2 Middle East and Africa Flumioxazin Revenue by Type (2017-2028)
11.2 Middle East and Africa Flumioxazin Market Size by Application
11.2.1 Middle East and Africa Flumioxazin Sales by Application (2017-2028)
11.2.2 Middle East and Africa Flumioxazin Revenue by Application (2017-2028)
11.3 Middle East and Africa Flumioxazin Sales by Country
11.3.1 Middle East and Africa Flumioxazin Sales by Country (2017-2028)
11.3.2 Middle East and Africa Flumioxazin Revenue by Country (2017-2028)
11.3.3 Turkey
11.3.4 Saudi Arabia
11.3.5 UAE
12 Corporate Profiles
12.1 Sumitomo Chemical
12.1.1 Sumitomo Chemical Corporation Information
12.1.2 Sumitomo Chemical Overview
12.1.3 Sumitomo Chemical Flumioxazin Sales, Price, Revenue and Gross Margin (2017-2022)
12.1.4 Sumitomo Chemical Flumioxazin Product Model Numbers, Pictures, Descriptions and Specifications
12.1.5 Sumitomo Chemical Recent Developments
12.2 Lier Chemical
12.2.1 Lier Chemical Corporation Information
12.2.2 Lier Chemical Overview
12.2.3 Lier Chemical Flumioxazin Sales, Price, Revenue and Gross Margin (2017-2022)
12.2.4 Lier Chemical Flumioxazin Product Model Numbers, Pictures, Descriptions and Specifications
12.2.5 Lier Chemical Recent Developments
12.3 Yifan Bio-tech Group
12.3.1 Yifan Bio-tech Group Corporation Information
12.3.2 Yifan Bio-tech Group Overview
12.3.3 Yifan Bio-tech Group Flumioxazin Sales, Price, Revenue and Gross Margin (2017-2022)
12.3.4 Yifan Bio-tech Group Flumioxazin Product Model Numbers, Pictures, Descriptions and Specifications
12.3.5 Yifan Bio-tech Group Recent Developments
12.4 Shangyu Nutrichem
12.4.1 Shangyu Nutrichem Corporation Information
12.4.2 Shangyu Nutrichem Overview
12.4.3 Shangyu Nutrichem Flumioxazin Sales, Price, Revenue and Gross Margin (2017-2022)
12.4.4 Shangyu Nutrichem Flumioxazin Product Model Numbers, Pictures, Descriptions and Specifications
12.4.5 Shangyu Nutrichem Recent Developments
12.5 Rainbow Agro
12.5.1 Rainbow Agro Corporation Information
12.5.2 Rainbow Agro Overview
12.5.3 Rainbow Agro Flumioxazin Sales, Price, Revenue and Gross Margin (2017-2022)
12.5.4 Rainbow Agro Flumioxazin Product Model Numbers, Pictures, Descriptions and Specifications
12.5.5 Rainbow Agro Recent Developments
12.6 Shandong Binnong Technology
12.6.1 Shandong Binnong Technology Corporation Information
12.6.2 Shandong Binnong Technology Overview
12.6.3 Shandong Binnong Technology Flumioxazin Sales, Price, Revenue and Gross Margin (2017-2022)
12.6.4 Shandong Binnong Technology Flumioxazin Product Model Numbers, Pictures, Descriptions and Specifications
12.6.5 Shandong Binnong Technology Recent Developments
12.7 ShanDong Cynda Chemical
12.7.1 ShanDong Cynda Chemical Corporation Information
12.7.2 ShanDong Cynda Chemical Overview
12.7.3 ShanDong Cynda Chemical Flumioxazin Sales, Price, Revenue and Gross Margin (2017-2022)
12.7.4 ShanDong Cynda Chemical Flumioxazin Product Model Numbers, Pictures, Descriptions and Specifications
12.7.5 ShanDong Cynda Chemical Recent Developments
12.8 Shandong Kesai Agrochem Holding
12.8.1 Shandong Kesai Agrochem Holding Corporation Information
12.8.2 Shandong Kesai Agrochem Holding Overview
12.8.3 Shandong Kesai Agrochem Holding Flumioxazin Sales, Price, Revenue and Gross Margin (2017-2022)
12.8.4 Shandong Kesai Agrochem Holding Flumioxazin Product Model Numbers, Pictures, Descriptions and Specifications
12.8.5 Shandong Kesai Agrochem Holding Recent Developments
12.9 Maxunitech
12.9.1 Maxunitech Corporation Information
12.9.2 Maxunitech Overview
12.9.3 Maxunitech Flumioxazin Sales, Price, Revenue and Gross Margin (2017-2022)
12.9.4 Maxunitech Flumioxazin Product Model Numbers, Pictures, Descriptions and Specifications
12.9.5 Maxunitech Recent Developments
13 Industry Chain and Sales Channels Analysis
13.1 Flumioxazin Industry Chain Analysis
13.2 Flumioxazin Key Raw Materials
13.2.1 Key Raw Materials
13.2.2 Raw Materials Key Suppliers
13.3 Flumioxazin Production Mode & Process
13.4 Flumioxazin Sales and Marketing
13.4.1 Flumioxazin Sales Channels
13.4.2 Flumioxazin Distributors
13.5 Flumioxazin Customers
14 Market Drivers, Opportunities, Challenges and Risks Factors Analysis
14.1 Flumioxazin Industry Trends
14.2 Flumioxazin Market Drivers
14.3 Flumioxazin Market Challenges
14.4 Flumioxazin Market Restraints
15 Key Finding in The Global Flumioxazin Study
16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer

List of Tables
Table 1. Global Flumioxazin Market Size Growth Rate by Type, 2017 VS 2021 VS 2028 (US$ Million)
Table 2. Major Manufacturers of Technical Material
Table 3. Major Manufacturers of Single Preparation
Table 4. Major Manufacturers of Compound Preparation
Table 5. Global Flumioxazin Market Size Growth Rate by Application, 2017 VS 2021 2028 (US$ Million)
Table 6. Global Flumioxazin Production by Region: 2017 VS 2021 VS 2028 (Tons)
Table 7. Global Flumioxazin Production by Region (2017-2022) & (Tons)
Table 8. Global Flumioxazin Production Market Share by Region (2017-2022)
Table 9. Global Flumioxazin Production by Region (2023-2028) & (Tons)
Table 10. Global Flumioxazin Production Market Share by Region (2023-2028)
Table 11. Global Flumioxazin Revenue by Region: 2017 VS 2021 VS 2028 (US$ Million)
Table 12. Global Flumioxazin Sales by Region (2017-2022) & (Tons)
Table 13. Global Flumioxazin Sales Market Share by Region (2017-2022)
Table 14. Global Flumioxazin Sales by Region (2023-2028) & (Tons)
Table 15. Global Flumioxazin Sales Market Share by Region (2023-2028)
Table 16. Global Flumioxazin Revenue by Region (2017-2022) & (US$ Million)
Table 17. Global Flumioxazin Revenue Market Share by Region (2017-2022)
Table 18. Global Flumioxazin Revenue by Region (2023-2028) & (US$ Million)
Table 19. Global Flumioxazin Revenue Market Share by Region (2023-2028)
Table 20. Global Flumioxazin Production Capacity by Manufacturers (2017-2022) & (Tons)
Table 21. Global Flumioxazin Capacity Market Share by Manufacturers (2017-2022)
Table 22. Global Flumioxazin Sales by Manufacturers (2017-2022) & (Tons)
Table 23. Global Flumioxazin Sales Market Share by Manufacturers (2017-2022)
Table 24. Global Flumioxazin Revenue by Manufacturers (2017-2022) & (US$ Million)
Table 25. Global Flumioxazin Revenue Share by Manufacturers (2017-2022)
Table 26. Flumioxazin Price by Manufacturers 2017-2022 (US$/Ton)
Table 27. Global Flumioxazin Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 28. Global Flumioxazin by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Flumioxazin as of 2021)
Table 29. Flumioxazin Manufacturing Base Distribution and Headquarters
Table 30. Manufacturers Flumioxazin Product Offered
Table 31. Date of Manufacturers Enter into Flumioxazin Market
Table 32. Mergers & Acquisitions, Expansion Plans
Table 33. Global Flumioxazin Sales by Type (2017-2022) & (Tons)
Table 34. Global Flumioxazin Sales by Type (2023-2028) & (Tons)
Table 35. Global Flumioxazin Sales Share by Type (2017-2022)
Table 36. Global Flumioxazin Sales Share by Type (2023-2028)
Table 37. Global Flumioxazin Revenue by Type (2017-2022) & (US$ Million)
Table 38. Global Flumioxazin Revenue by Type (2023-2028) & (US$ Million)
Table 39. Global Flumioxazin Revenue Share by Type (2017-2022)
Table 40. Global Flumioxazin Revenue Share by Type (2023-2028)
Table 41. Flumioxazin Price by Type (2017-2022) & (US$/Ton)
Table 42. Global Flumioxazin Price Forecast by Type (2023-2028) & (US$/Ton)
Table 43. Global Flumioxazin Sales by Application (2017-2022) & (Tons)
Table 44. Global Flumioxazin Sales by Application (2023-2028) & (Tons)
Table 45. Global Flumioxazin Sales Share by Application (2017-2022)
Table 46. Global Flumioxazin Sales Share by Application (2023-2028)
Table 47. Global Flumioxazin Revenue by Application (2017-2022) & (US$ Million)
Table 48. Global Flumioxazin Revenue by Application (2023-2028) & (US$ Million)
Table 49. Global Flumioxazin Revenue Share by Application (2017-2022)
Table 50. Global Flumioxazin Revenue Share by Application (2023-2028)
Table 51. Flumioxazin Price by Application (2017-2022) & (US$/Ton)
Table 52. Global Flumioxazin Price Forecast by Application (2023-2028) & (US$/Ton)
Table 53. North America Flumioxazin Sales by Type (2017-2022) & (Tons)
Table 54. North America Flumioxazin Sales by Type (2023-2028) & (Tons)
Table 55. North America Flumioxazin Revenue by Type (2017-2022) & (US$ Million)
Table 56. North America Flumioxazin Revenue by Type (2023-2028) & (US$ Million)
Table 57. North America Flumioxazin Sales by Application (2017-2022) & (Tons)
Table 58. North America Flumioxazin Sales by Application (2023-2028) & (Tons)
Table 59. North America Flumioxazin Revenue by Application (2017-2022) & (US$ Million)
Table 60. North America Flumioxazin Revenue by Application (2023-2028) & (US$ Million)
Table 61. North America Flumioxazin Sales by Country (2017-2022) & (Tons)
Table 62. North America Flumioxazin Sales by Country (2023-2028) & (Tons)
Table 63. North America Flumioxazin Revenue by Country (2017-2022) & (US$ Million)
Table 64. North America Flumioxazin Revenue by Country (2023-2028) & (US$ Million)
Table 65. Europe Flumioxazin Sales by Type (2017-2022) & (Tons)
Table 66. Europe Flumioxazin Sales by Type (2023-2028) & (Tons)
Table 67. Europe Flumioxazin Revenue by Type (2017-2022) & (US$ Million)
Table 68. Europe Flumioxazin Revenue by Type (2023-2028) & (US$ Million)
Table 69. Europe Flumioxazin Sales by Application (2017-2022) & (Tons)
Table 70. Europe Flumioxazin Sales by Application (2023-2028) & (Tons)
Table 71. Europe Flumioxazin Revenue by Application (2017-2022) & (US$ Million)
Table 72. Europe Flumioxazin Revenue by Application (2023-2028) & (US$ Million)
Table 73. Europe Flumioxazin Sales by Country (2017-2022) & (Tons)
Table 74. Europe Flumioxazin Sales by Country (2023-2028) & (Tons)
Table 75. Europe Flumioxazin Revenue by Country (2017-2022) & (US$ Million)
Table 76. Europe Flumioxazin Revenue by Country (2023-2028) & (US$ Million)
Table 77. Asia Pacific Flumioxazin Sales by Type (2017-2022) & (Tons)
Table 78. Asia Pacific Flumioxazin Sales by Type (2023-2028) & (Tons)
Table 79. Asia Pacific Flumioxazin Revenue by Type (2017-2022) & (US$ Million)
Table 80. Asia Pacific Flumioxazin Revenue by Type (2023-2028) & (US$ Million)
Table 81. Asia Pacific Flumioxazin Sales by Application (2017-2022) & (Tons)
Table 82. Asia Pacific Flumioxazin Sales by Application (2023-2028) & (Tons)
Table 83. Asia Pacific Flumioxazin Revenue by Application (2017-2022) & (US$ Million)
Table 84. Asia Pacific Flumioxazin Revenue by Application (2023-2028) & (US$ Million)
Table 85. Asia Pacific Flumioxazin Sales by Region (2017-2022) & (Tons)
Table 86. Asia Pacific Flumioxazin Sales by Region (2023-2028) & (Tons)
Table 87. Asia Pacific Flumioxazin Revenue by Region (2017-2022) & (US$ Million)
Table 88. Asia Pacific Flumioxazin Revenue by Region (2023-2028) & (US$ Million)
Table 89. Latin America Flumioxazin Sales by Type (2017-2022) & (Tons)
Table 90. Latin America Flumioxazin Sales by Type (2023-2028) & (Tons)
Table 91. Latin America Flumioxazin Revenue by Type (2017-2022) & (US$ Million)
Table 92. Latin America Flumioxazin Revenue by Type (2023-2028) & (US$ Million)
Table 93. Latin America Flumioxazin Sales by Application (2017-2022) & (Tons)
Table 94. Latin America Flumioxazin Sales by Application (2023-2028) & (Tons)
Table 95. Latin America Flumioxazin Revenue by Application (2017-2022) & (US$ Million)
Table 96. Latin America Flumioxazin Revenue by Application (2023-2028) & (US$ Million)
Table 97. Latin America Flumioxazin Sales by Country (2017-2022) & (Tons)
Table 98. Latin America Flumioxazin Sales by Country (2023-2028) & (Tons)
Table 99. Latin America Flumioxazin Revenue by Country (2017-2022) & (US$ Million)
Table 100. Latin America Flumioxazin Revenue by Country (2023-2028) & (US$ Million)
Table 101. Middle East and Africa Flumioxazin Sales by Type (2017-2022) & (Tons)
Table 102. Middle East and Africa Flumioxazin Sales by Type (2023-2028) & (Tons)
Table 103. Middle East and Africa Flumioxazin Revenue by Type (2017-2022) & (US$ Million)
Table 104. Middle East and Africa Flumioxazin Revenue by Type (2023-2028) & (US$ Million)
Table 105. Middle East and Africa Flumioxazin Sales by Application (2017-2022) & (Tons)
Table 106. Middle East and Africa Flumioxazin Sales by Application (2023-2028) & (Tons)
Table 107. Middle East and Africa Flumioxazin Revenue by Application (2017-2022) & (US$ Million)
Table 108. Middle East and Africa Flumioxazin Revenue by Application (2023-2028) & (US$ Million)
Table 109. Middle East and Africa Flumioxazin Sales by Country (2017-2022) & (Tons)
Table 110. Middle East and Africa Flumioxazin Sales by Country (2023-2028) & (Tons)
Table 111. Middle East and Africa Flumioxazin Revenue by Country (2017-2022) & (US$ Million)
Table 112. Middle East and Africa Flumioxazin Revenue by Country (2023-2028) & (US$ Million)
Table 113. Sumitomo Chemical Corporation Information
Table 114. Sumitomo Chemical Description and Major Businesses
Table 115. Sumitomo Chemical Flumioxazin Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2017-2022)
Table 116. Sumitomo Chemical Flumioxazin Product Model Numbers, Pictures, Descriptions and Specifications
Table 117. Sumitomo Chemical Recent Development
Table 118. Lier Chemical Corporation Information
Table 119. Lier Chemical Description and Major Businesses
Table 120. Lier Chemical Flumioxazin Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2017-2022)
Table 121. Lier Chemical Flumioxazin Product Model Numbers, Pictures, Descriptions and Specifications
Table 122. Lier Chemical Recent Development
Table 123. Yifan Bio-tech Group Corporation Information
Table 124. Yifan Bio-tech Group Description and Major Businesses
Table 125. Yifan Bio-tech Group Flumioxazin Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2017-2022)
Table 126. Yifan Bio-tech Group Flumioxazin Product Model Numbers, Pictures, Descriptions and Specifications
Table 127. Yifan Bio-tech Group Recent Development
Table 128. Shangyu Nutrichem Corporation Information
Table 129. Shangyu Nutrichem Description and Major Businesses
Table 130. Shangyu Nutrichem Flumioxazin Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2017-2022)
Table 131. Shangyu Nutrichem Flumioxazin Product Model Numbers, Pictures, Descriptions and Specifications
Table 132. Shangyu Nutrichem Recent Development
Table 133. Rainbow Agro Corporation Information
Table 134. Rainbow Agro Description and Major Businesses
Table 135. Rainbow Agro Flumioxazin Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2017-2022)
Table 136. Rainbow Agro Flumioxazin Product Model Numbers, Pictures, Descriptions and Specifications
Table 137. Rainbow Agro Recent Development
Table 138. Shandong Binnong Technology Corporation Information
Table 139. Shandong Binnong Technology Description and Major Businesses
Table 140. Shandong Binnong Technology Flumioxazin Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2017-2022)
Table 141. Shandong Binnong Technology Flumioxazin Product Model Numbers, Pictures, Descriptions and Specifications
Table 142. Shandong Binnong Technology Recent Development
Table 143. ShanDong Cynda Chemical Corporation Information
Table 144. ShanDong Cynda Chemical Description and Major Businesses
Table 145. ShanDong Cynda Chemical Flumioxazin Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2017-2022)
Table 146. ShanDong Cynda Chemical Flumioxazin Product Model Numbers, Pictures, Descriptions and Specifications
Table 147. ShanDong Cynda Chemical Recent Development
Table 148. Shandong Kesai Agrochem Holding Corporation Information
Table 149. Shandong Kesai Agrochem Holding Description and Major Businesses
Table 150. Shandong Kesai Agrochem Holding Flumioxazin Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2017-2022)
Table 151. Shandong Kesai Agrochem Holding Flumioxazin Product Model Numbers, Pictures, Descriptions and Specifications
Table 152. Shandong Kesai Agrochem Holding Recent Development
Table 153. Maxunitech Corporation Information
Table 154. Maxunitech Description and Major Businesses
Table 155. Maxunitech Flumioxazin Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2017-2022)
Table 156. Maxunitech Flumioxazin Product Model Numbers, Pictures, Descriptions and Specifications
Table 157. Maxunitech Recent Development
Table 158. Key Raw Materials Lists
Table 159. Raw Materials Key Suppliers Lists
Table 160. Flumioxazin Distributors List
Table 161. Flumioxazin Customers List
Table 162. Flumioxazin Market Trends
Table 163. Flumioxazin Market Drivers
Table 164. Flumioxazin Market Challenges
Table 165. Flumioxazin Market Restraints
Table 166. Research Programs/Design for This Report
Table 167. Key Data Information from Secondary Sources
Table 168. Key Data Information from Primary Sources
List of Figures
Figure 1. Flumioxazin Product Picture
Figure 2. Global Flumioxazin Market Share by Type in 2021 & 2028
Figure 3. Technical Material Product Picture
Figure 4. Single Preparation Product Picture
Figure 5. Compound Preparation Product Picture
Figure 6. Global Flumioxazin Market Share by Application in 2021 & 2028
Figure 7. Soybean
Figure 8. Sugar Cane
Figure 9. Cotton
Figure 10. Other
Figure 11. Flumioxazin Report Years Considered
Figure 12. Global Flumioxazin Capacity, Production and Utilization (2017-2028) & (Tons)
Figure 13. Global Flumioxazin Production Market Share by Region in Percentage: 2021 Versus 2028
Figure 14. Global Flumioxazin Production Market Share by Region (2017-2022)
Figure 15. Global Flumioxazin Production Market Share by Region (2023-2028)
Figure 16. Flumioxazin Production Growth Rate in North America (2017-2028) & (Tons)
Figure 17. Flumioxazin Production Growth Rate in Europe (2017-2028) & (Tons)
Figure 18. Flumioxazin Production Growth Rate in China (2017-2028) & (Tons)
Figure 19. Flumioxazin Production Growth Rate in Japan (2017-2028) & (Tons)
Figure 20. Global Flumioxazin Sales 2017-2028 (Tons)
Figure 21. Global Flumioxazin Revenue, (US$ Million), 2017 VS 2021 VS 2028
Figure 22. Global Flumioxazin Revenue 2017-2028 (US$ Million)
Figure 23. Global Flumioxazin Revenue Market Share by Region in Percentage: 2021 Versus 2028
Figure 24. Global Flumioxazin Sales Market Share by Region (2017-2022)
Figure 25. Global Flumioxazin Sales Market Share by Region (2023-2028)
Figure 26. North America Flumioxazin Sales YoY (2017-2028) & (Tons)
Figure 27. North America Flumioxazin Revenue YoY (2017-2028) & (US$ Million)
Figure 28. Europe Flumioxazin Sales YoY (2017-2028) & (Tons)
Figure 29. Europe Flumioxazin Revenue YoY (2017-2028) & (US$ Million)
Figure 30. Asia-Pacific Flumioxazin Sales YoY (2017-2028) & (Tons)
Figure 31. Asia-Pacific Flumioxazin Revenue YoY (2017-2028) & (US$ Million)
Figure 32. Latin America Flumioxazin Sales YoY (2017-2028) & (Tons)
Figure 33. Latin America Flumioxazin Revenue YoY (2017-2028) & (US$ Million)
Figure 34. Middle East & Africa Flumioxazin Sales YoY (2017-2028) & (Tons)
Figure 35. Middle East & Africa Flumioxazin Revenue YoY (2017-2028) & (US$ Million)
Figure 36. The Flumioxazin Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2021
Figure 37. The Top 5 and 10 Largest Manufacturers of Flumioxazin in the World: Market Share by Flumioxazin Revenue in 2021
Figure 38. Flumioxazin Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2017 VS 2021
Figure 39. Global Flumioxazin Sales Market Share by Type (2017-2028)
Figure 40. Global Flumioxazin Revenue Market Share by Type (2017-2028)
Figure 41. Global Flumioxazin Sales Market Share by Application (2017-2028)
Figure 42. Global Flumioxazin Revenue Market Share by Application (2017-2028)
Figure 43. North America Flumioxazin Sales Market Share by Type (2017-2028)
Figure 44. North America Flumioxazin Revenue Market Share by Type (2017-2028)
Figure 45. North America Flumioxazin Sales Market Share by Application (2017-2028)
Figure 46. North America Flumioxazin Revenue Market Share by Application (2017-2028)
Figure 47. North America Flumioxazin Sales Share by Country (2017-2028)
Figure 48. North America Flumioxazin Revenue Share by Country (2017-2028)
Figure 49. United States Flumioxazin Revenue (2017-2028) & (US$ Million)
Figure 50. Canada Flumioxazin Revenue (2017-2028) & (US$ Million)
Figure 51. Europe Flumioxazin Sales Market Share by Type (2017-2028)
Figure 52. Europe Flumioxazin Revenue Market Share by Type (2017-2028)
Figure 53. Europe Flumioxazin Sales Market Share by Application (2017-2028)
Figure 54. Europe Flumioxazin Revenue Market Share by Application (2017-2028)
Figure 55. Europe Flumioxazin Sales Share by Country (2017-2028)
Figure 56. Europe Flumioxazin Revenue Share by Country (2017-2028)
Figure 57. Germany Flumioxazin Revenue (2017-2028) & (US$ Million)
Figure 58. France Flumioxazin Revenue (2017-2028) & (US$ Million)
Figure 59. U.K. Flumioxazin Revenue (2017-2028) & (US$ Million)
Figure 60. Italy Flumioxazin Revenue (2017-2028) & (US$ Million)
Figure 61. Russia Flumioxazin Revenue (2017-2028) & (US$ Million)
Figure 62. Asia Pacific Flumioxazin Sales Market Share by Type (2017-2028)
Figure 63. Asia Pacific Flumioxazin Revenue Market Share by Type (2017-2028)
Figure 64. Asia Pacific Flumioxazin Sales Market Share by Application (2017-2028)
Figure 65. Asia Pacific Flumioxazin Revenue Market Share by Application (2017-2028)
Figure 66. Asia Pacific Flumioxazin Sales Share by Region (2017-2028)
Figure 67. Asia Pacific Flumioxazin Revenue Share by Region (2017-2028)
Figure 68. China Flumioxazin Revenue (2017-2028) & (US$ Million)
Figure 69. Japan Flumioxazin Revenue (2017-2028) & (US$ Million)
Figure 70. South Korea Flumioxazin Revenue (2017-2028) & (US$ Million)
Figure 71. India Flumioxazin Revenue (2017-2028) & (US$ Million)
Figure 72. Australia Flumioxazin Revenue (2017-2028) & (US$ Million)
Figure 73. China Taiwan Flumioxazin Revenue (2017-2028) & (US$ Million)
Figure 74. Indonesia Flumioxazin Revenue (2017-2028) & (US$ Million)
Figure 75. Thailand Flumioxazin Revenue (2017-2028) & (US$ Million)
Figure 76. Malaysia Flumioxazin Revenue (2017-2028) & (US$ Million)
Figure 77. Latin America Flumioxazin Sales Market Share by Type (2017-2028)
Figure 78. Latin America Flumioxazin Revenue Market Share by Type (2017-2028)
Figure 79. Latin America Flumioxazin Sales Market Share by Application (2017-2028)
Figure 80. Latin America Flumioxazin Revenue Market Share by Application (2017-2028)
Figure 81. Latin America Flumioxazin Sales Share by Country (2017-2028)
Figure 82. Latin America Flumioxazin Revenue Share by Country (2017-2028)
Figure 83. Mexico Flumioxazin Revenue (2017-2028) & (US$ Million)
Figure 84. Brazil Flumioxazin Revenue (2017-2028) & (US$ Million)
Figure 85. Argentina Flumioxazin Revenue (2017-2028) & (US$ Million)
Figure 86. Colombia Flumioxazin Revenue (2017-2028) & (US$ Million)
Figure 87. Middle East and Africa Flumioxazin Sales Market Share by Type (2017-2028)
Figure 88. Middle East and Africa Flumioxazin Revenue Market Share by Type (2017-2028)
Figure 89. Middle East and Africa Flumioxazin Sales Market Share by Application (2017-2028)
Figure 90. Middle East and Africa Flumioxazin Revenue Market Share by Application (2017-2028)
Figure 91. Middle East and Africa Flumioxazin Sales Share by Country (2017-2028)
Figure 92. Middle East and Africa Flumioxazin Revenue Share by Country (2017-2028)
Figure 93. Turkey Flumioxazin Revenue (2017-2028) & (US$ Million)
Figure 94. Saudi Arabia Flumioxazin Revenue (2017-2028) & (US$ Million)
Figure 95. UAE Flumioxazin Revenue (2017-2028) & (US$ Million)
Figure 96. Flumioxazin Value Chain
Figure 97. Flumioxazin Production Process
Figure 98. Channels of Distribution
Figure 99. Distributors Profiles
Figure 100. Bottom-up and Top-down Approaches for This Report
Figure 101. Data Triangulation
Figure 102. Key Executives Interviewed